EAM
BSX icon

EFG Asset Management’s Boston Scientific BSX Stock Holding History

EFG Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,930
Closed -$2.67M – 181
2024
Q4 		$2.67M Buy
29,930
+2,527
+9% +$222K 0.37% 121
2024
Q3 		$2.3M Sell
27,403
-9,474
-26% -$747K 0.38% 113
2024
Q2 		$2.84M Sell
36,877
-1,452
-4% -$106K 0.49% 64
2024
Q1 		$2.62M Sell
38,329
-199
-0.5% -$12.8K 0.45% 78
2023
Q4 		$2.23M Buy
38,528
+20,880
+118% +$1.11M 0.42% 93
2023
Q3 		$932K Sell
17,648
-373
-2% -$19.6K 0.22% 148
2023
Q2 		$974K Buy
+18,021
New +$941K 0.21% 157

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EFG Asset Management's BSX Position: Q1 2025 in Review

EFG Asset Management sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 29,930 shares — an estimated $2.67M sold.

EFG Asset Management first reported a position in BSX in Q2 2023 and held it in 7 quarters. The position peaked at $2.84M in Q2 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • EFG Asset Management reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • EFG Asset Management sold 29,930 Boston Scientific shares in Q1 2025, an estimated $2.67M.
  • EFG Asset Management first reported a position in Boston Scientific in Q2 2023 and held it in 7 quarters.
  • EFG Asset Management's Boston Scientific position peaked at $2.84M in Q2 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on EFG Asset Management's 13F filing for Q1 2025, filed 15 May 2025.